Barclays’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.88M | Buy |
154,871
+73,567
| +90% | +$3.74M | ﹤0.01% | 1294 |
|
|
2025
Q1 | $3.66M | Sell |
81,304
-170,660
| -68% | -$7.69M | ﹤0.01% | 1618 |
|
|
2024
Q4 | $10.4M | Buy |
251,964
+6,046
| +2% | +$250K | ﹤0.01% | 1100 |
|
|
2024
Q3 | $9.59M | Buy |
245,918
+10,824
| +5% | +$422K | ﹤0.01% | 1068 |
|
|
2024
Q2 | $8.04M | Sell |
235,094
-39,772
| -14% | -$1.36M | ﹤0.01% | 982 |
|
|
2024
Q1 | $6.9M | Buy |
274,866
+174,944
| +175% | +$4.39M | ﹤0.01% | 1211 |
|
|
2023
Q4 | $2.95M | Sell |
99,922
-199,198
| -67% | -$5.88M | ﹤0.01% | 1881 |
|
|
2023
Q3 | $9.45M | Buy |
299,120
+11,970
| +4% | +$378K | 0.01% | 884 |
|
|
2023
Q2 | $7.43M | Sell |
287,150
-12,313
| -4% | -$319K | ﹤0.01% | 1024 |
|
|
2023
Q1 | $7.19M | Sell |
299,463
-78,109
| -21% | -$1.88M | ﹤0.01% | 928 |
|
|
2022
Q4 | $7.36M | Buy |
377,572
+288,695
| +325% | +$5.63M | ﹤0.01% | 939 |
|
|
2022
Q3 | $1.87M | Buy |
88,877
+65,621
| +282% | +$1.38M | ﹤0.01% | 1703 |
|
|
2022
Q2 | $453K | Sell |
23,256
-6,063
| -21% | -$118K | ﹤0.01% | 2652 |
|
|
2022
Q1 | $646K | Buy |
+29,319
| New | +$646K | ﹤0.01% | 2619 |
|